Botulinum toxin, derives from the bacteria Clostridium Botulinum.
Botulinum toxin is thought to act by two distinct mechanisms. It has a direct pain killing effect (anti-nociceptive effect) as a result of blocking central transmission of pain impulses from the periphery to the brain. It also acts on muscle nerves resetting the level of contraction and thereby reducing muscle spasm.
Whilst the number of clinical indications for botulinum toxin has escalated dramatically over the last 5 years it is not a new drug or novel technique. It has been used cosmetically for around 15 years and indeed some of its beneficial effects in terms of pain alleviation were discovered from its use cosmetically. An example of this is the use of botulinum toxin in migraine prophylaxis where early indications of its potential benefit were derived from patients undergoing cosmetic treatment with Botox and noting a decrease in the frequency and severity of their migraine headaches.
It may be given in a number of different conditions and studies are now emerging indicating its effectiveness in the treatment of:
- painful neck pain associated with muscle spasm
- piriformis syndrome
- complex regional pain syndrome
- lower back pain associated with muscle spasm
- migraine